TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Vaccine development: Where do we stand?

  • The Jakarta Post

PREMIUM
Jakarta   /   Tue, October 27 2020   /  01:00 am
Vaccine development in Indonesia(JP/Swi Handono)

Pharmaceutical companies from across the globe are racing to develop COVID-19 vaccines. Reuters reported that, as of August, there were more than 200 vaccine candidates in development globally, including more than 20 in human trials. In Indonesia, a potential vaccine developed by China-based biopharmaceutical company Sinovac Biotech entered the phase three clinical trials in August.  Bambang Heriyanto, corporate secretary of state-owned pharmaceutical holding company PT Bio Farma, said on Monday that, as of Oct. 16, 1,620 volunteers had received the first injection of the potential COVID-19 vaccine, 1,074 volunteers had received the second injection and 671 volunteers had undergone blood tests after receiving the second injection. With all eyes on COVID-19 vaccine, the National COVID-19 task force experts team coordinator and spokesperson Wiku Adisasmito tried to explain...